Gluconic Acid

Gluconic Acid

SCHEMBL2548636

O.O.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Fe+3]

nearest known ligand 0.87

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.87
PDE4A P27815 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.50
USP2 O75604 1/20 0.48
SLCO1B1 Q9Y6L6 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
OR51E2 Q9H255 1/20 0.39
KDM4E B2RXH2 2/20 0.37
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CA4 P22748 2/20 0.31
TOP1 P11387 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gluconic Acid SCHEMBL1078281 1.00 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL3717039 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL141069 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL3768828 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL6653232 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL22983955 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL721131 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL23566696 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL21082704 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL22442432 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023215815-A1 DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF DABDOUB ATIF (US) 2023-11-09 WO claimed
US-4499076-A AMINO ACIDS, CARBOHYDRATES FATS, VITAMINS AND MINERALS AJINOMOTO COMPANY INCORPORATED (JP) 1985-02-12 US claimed
US-12629373-B2 Dietary macro/micronutritional compositions and applications thereof Dabdoub, Atif (US) 2026-05-19 US disclosed
US-20260083739-A1 DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF DABDOUB ATIF (US) 2026-03-26 US disclosed
WO-2025071432-A1 PHARMACEUTICAL AGENT FOR TREATING JOINT DISEASES Общество с ограниченной ответственностью "ДИАМЕД-фарма" 2025-04-03 WO disclosed
US-20250057842-A1 DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF DABDOUB ATIF (US) 2025-02-20 US disclosed
WO-2023215815-A1 DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF DABDOUB ATIF (US) 2023-11-09 WO disclosed
US-20210353578-A1 DIETARY MACRO/MICRONUTRITIONAL SUPPLEMENT FOR PATIENTS UNDERGOING KIDNEY DIALYSIS DABDOUB ATIF (US) 2021-11-18 US disclosed
EP-3503745-B1 DIETARY MACRO/MICRONUTRITIONAL SUPPLEMENT FOR PATIENTS UNDERGOING KIDNEY DIALYSIS DABDOUB ATIF (US) 2021-10-27 EP disclosed
US-11077085-B2 Dietary macro/micronutritional supplement for patients undergoing kidney dialysis Dabdoub, Atif (US) 2021-08-03 US disclosed
WO-2019165222-A1 DIETARY MACRO/MICRONUTRITIONAL SUPPLEMENT AND APPLICATIONS THEREOF DABDOUB ATIF (US) 2019-08-29 WO disclosed
US-9620775-B2 Method for producing carbon-coated metal-doped zinc oxide articles and the use thereof Westfälische Wilhelms-Universität Münster (DE) 2017-04-11 US disclosed
US-20150214541-A1 METHOD FOR PRODUCING CARBON-COATED METAL-DOPED ZINC OXIDE ARTICLES AND THE USE THEREOF Westfälische Wilhelms-Universität Münster (DE) 2015-07-30 US disclosed
US-20140356760-A1 NITROGEN-CONTAINING CARBON ALLOY, METHOD FOR PRODUCING SAME, CARBON ALLOY CATALYST, AND FUEL CELL FUJIFILM CORPORATION (JP) 2014-12-04 US disclosed
WO-2011124910-A2 SELF HEATING PACKAGING AND METHOD OF MANUFACTURING FUEL NANO HEATING COMPANY LIMITED (GB) 2011-10-13 WO disclosed
EP-0265099-B1 NUTRIENT COMPOSITION AJINOMOTO CO., INC. (JP) 1992-01-22 EP disclosed
EP-0265099-A2 Nutrient composition AJINOMOTO CO., INC. (JP) 1988-04-27 EP disclosed
US-4499076-A AMINO ACIDS, CARBOHYDRATES FATS, VITAMINS AND MINERALS AJINOMOTO COMPANY INCORPORATED (JP) 1985-02-12 US disclosed
EP-0034034-B1 NUTRIENT COMPOSITION AJINOMOTO CO., INC. (JP) 1983-10-05 EP disclosed
EP-0034034-A1 Nutrient composition AJINOMOTO CO., INC. (JP) 1981-08-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12629373-B2 Dietary macro/micronutritional compositions and applications thereof CPT1B, SLC39A3, SLC2A3 LMNA 1174/4885PDE4A 1777/4885L3MBTL1 2692/4885
US-20260083739-A1 DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF CPT1B, SLC39A3, SOD1 LMNA 1399/4885PDE4A 1010/4885L3MBTL1 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.